tiprankstipranks
Ligand Pharma (CH:LGDN)
:LGDN
Switzerland Market

Ligand Pharma (LGDN) Earnings Dates, Call Summary & Reports

0 Followers

Earnings Data

Report Date
Nov 05, 2026
After Close (Confirmed)
Period Ending
2026 (Q3)
Consensus EPS Forecast
1.87
Last Year’s EPS
2.51
Same Quarter Last Year
Based on 8 Analysts Ratings

Ligand Pharma (CH:LGDN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CH:LGDN Q2 2026 Earnings Report

CH:LGDN Upcoming Earnings
Ligand Pharma's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

CH:LGDN Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Nov 05, 2026
2026 (Q3)
1.87 / -
2.506
2026 (Q2)
1.63 / 1.92
1.29848.13% (+0.62)
2026 (Q1)
1.47 / 1.32
1.07922.56% (+0.24)
2025 (Q4)
1.21 / 1.64
1.0359.06% (+0.61)
2025 (Q3)
1.56 / 2.51
1.49267.93% (+1.01)
2025 (Q2)
1.15 / 1.30
1.13614.29% (+0.16)
2025 (Q1)
0.98 / 1.08
0.97310.83% (+0.11)
2024 (Q4)
0.97 / 1.03
1.119-7.97% (-0.09)
2024 (Q3)
1.09 / 1.49
0.82780.39% (+0.67)
2024 (Q2)
0.86 / 1.14
1.152-1.41% (-0.02)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

FAQ

When does Ligand Pharma (CH:LGDN) report earnings?
Ligand Pharma (CH:LGDN) is schdueled to report earning on Nov 05, 2026, After Close (Confirmed).
    What is Ligand Pharma (CH:LGDN) earnings time?
    Ligand Pharma (CH:LGDN) earnings time is at Nov 05, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Ligand Pharma stock?
          The P/E ratio of Ligand Pharma is N/A.
            What is CH:LGDN EPS forecast?
            CH:LGDN EPS forecast for the fiscal quarter 2026 (Q3) is 1.87.